U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. How Drugs are Developed and Approved
  5. Types of Applications
  6. Therapeutic Biologics Applications (BLA)
  7. Biosimilars
  8. FDA Webinar - Overview of the Regulatory Framework and FDA’s Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US
  1. Biosimilars

FDA Webinar - Overview of the Regulatory Framework and FDA’s Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US

The FDA recorded a webinar titled, “FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US”. Dr. Sue Lim, M.D., Director of the Scientific Staff, Therapeutic Biologics and Biosimilars Team, CDER, FDA presented information on the regulation and development process of biosimilar and interchangeable products. This webinar was recorded to help FDA Advisory Committee members and Special Government Employees gain insight into the regulatory framework and key concepts about biosimilar and interchangeable products.

 

Back to Top